Pharmacokinetics (PK) Services

PK Bioanalysis That Drives Confident Decisions

Pharmacokinetic data is foundational to understanding exposure, dose, and therapeutic performance. BioAgilytix works alongside your team to develop and execute PK strategies that generate reliable, high-quality data at the scale required for global programs, supporting faster decisions and confident progression through development.

Speak to a Scientist

Solutions Bioanalytical Services Pharmacokinetics (PK) Services

Pharmacokinetic Expertise Backed by Scientific Depth and Global Scale

Preclinical through clinical PK support

Consistent data supporting study progression and decision-making

Broad modality experience

Supporting all modalities from small molecules, biologics, to advanced therapeutics

Global bioanalytical infrastructure

Designed to support high-throughput PK analysis across complex and global programs

When PK Strategy Impacts Program Progression

PK analysis is more than measuring concentration over time. Assay design, platform selection, and matrix complexity all influence data quality and interpretation.

Many approaches can generate PK data. Fewer generate data that is reliable, reproducible, and aligned with regulatory expectations.

BioAgilytix works with your team to define PK strategies based on your therapeutic, study design, and development phase, ensuring the data supports dose selection, exposure analysis, and confident clinical decision-making.

Speak to a Scientist

Comprehensive PK Bioanalytical Support

BioAgilytix supports PK analysis across modalities, species, and matrices, delivering reliable, high-quality data aligned with regulatory expectations and study timelines.

Assay Development & Validation

Design and validation of PK assays aligned to regulatory requirements

High-Throughput Sample Analysis

Scalable sample analysis supporting preclinical and clinical studies.

Multi-Species Support

Rodents, non-human primates, and human studies.

Matrix Expertise

Serum, plasma, urine, saliva, and complex biological matrices.

As your program evolves, your bioanalytical strategy must evolve with it. BioAgilytix adapts with your program, ensuring consistency, speed, and data integrity at every stage.

Antibody binding to human cell receptors

PK Expertise Across Therapeutic Modalities

BioAgilytix supports PK analysis across a wide range of therapeutic types, ensuring assay design aligns with the unique characteristics of each modality.

How can you overcome the most common challenges in PK bioanalysis?

PK studies depend on assay performance, matrix behavior, and method selection. Early missteps can introduce variability, delay timelines, or limit interpretability.

Inadequate assay sensitivity Low sensitivity can results in incomplete PK profiles or missed exposure data.	➔ Our Solution Align assay sensitivity with expected concentration ranges and study requirements.
Matrix interference or variability Biological matrices can impact assay performance and reproducibility.	➔ Our Solution Optimize matrix interference early in method development.
Improper method selection The wrong platform can limit sensitivity, specificity, or scalability.	➔ Our Solution Select methods based on therapeutic type, matrix, and study objectives.
Lack of phase-appropriate strategy Using the same approach across all phases can create inefficiencies or regulatory gaps	➔ Our Solution Adapt PK strategies as programs progress and data requirements evolve.

BioAgilytix works alongside your team to anticipate these challenges early, ensuring PK data supports reliable interpretation and efficient program progression.

A Scientific and Regulatory Partner in PK Strategy and Execution

BioAgilytix partners with your team to define the right PK approach before assay development begins, aligning strategy with the therapeutic, study design, and regulatory expectations. Our scientists develop and validate PK assays that meet global regulatory standards, including FDA, EMA, and ICH guidance, ensuring methods are well-characterized, reproducible, and submission ready. With scalable teams and harmonized processes, BioAgilytix supports efficient study timelines while maintaining the data integrity required for clinical and regulatory decision-making.

speak to a scientist